Randomized, double‐blind, phase III clinical study of a novel nanotechnological topical anesthetic formulation containing lidocaine 25 mg/g and prilocaine 25 mg/g (nanorap) in skin phototypes I–III patients with ablative fractional CO
            2
            laser treatment indication in the forehead

Cíntia Gobbato; André Gobbato; Tainah B. Magalhães; Gustavo D. Mendes; Jaime O. Ilha; Ronilson A. Moreno; Natalícia J. Antunes; Gilberto De Nucci

doi:10.1002/lsm.23071

Randomized, double‐blind, phase III clinical study of a novel nanotechnological topical anesthetic formulation containing lidocaine 25 mg/g and prilocaine 25 mg/g (nanorap) in skin phototypes I–III patients with ablative fractional CO 2 laser treatment indication in the forehead

Lasers in Surgery and Medicine ◽

10.1002/lsm.23071 ◽

2019 ◽

Vol 51 (7) ◽

pp. 609-615 ◽

Cited By ~ 2

Author(s):

Cíntia Gobbato ◽

André Gobbato ◽

Tainah B. Magalhães ◽

Gustavo D. Mendes ◽

Jaime O. Ilha ◽

...

Keyword(s):

Clinical Study ◽

Laser Treatment ◽

Phase Iii ◽

Topical Anesthetic ◽

Double Blind ◽

Treatment Indication

Download Full-text

Safety and efficacy of alternating treatment with EP2006, a filgrastim biosimilar, and reference filgrastim: a phase III, randomised, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy

Annals of Oncology ◽

10.1093/annonc/mdx638 ◽

2018 ◽

Vol 29 (1) ◽

pp. 244-249 ◽

Cited By ~ 10

Author(s):

K. Blackwell ◽

P. Gascon ◽

A. Krendyukov ◽

S. Gattu ◽

Y. Li ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Study ◽

Phase Iii ◽

Severe Neutropenia ◽

Double Blind ◽

Myelosuppressive Chemotherapy ◽

Safety And Efficacy

Download Full-text

Efficacy and Safety of a Fixed-Dose Combination of Candesartan and Rosuvastatin on Blood Pressure and Cholesterol in Patients With Hypertension and Hypercholesterolemia: A Multicenter, Randomized, Double-Blind, Parallel Phase III Clinical Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2019.05.007 ◽

2019 ◽

Vol 41 (8) ◽

pp. 1508-1521 ◽

Cited By ~ 3

Author(s):

Kyoung Im Cho ◽

Bo Hyun Kim ◽

Yong Hyun Park ◽

Jeong-Cheon Ahn ◽

Sang Hyun Kim ◽

...

Keyword(s):

Blood Pressure ◽

Clinical Study ◽

Fixed Dose Combination ◽

Phase Iii ◽

Fixed Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Dose Combination

Download Full-text

Efficacy and safety of RGB-02, a proposed biosimilar pegfilgrastim to prevent chemotherapy-induced neutropenia: Results of a randomized, double-blind, phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving docetaxel/doxorubicin

Annals of Oncology ◽

10.1093/annonc/mdx388.033 ◽

2017 ◽

Vol 28 ◽

pp. v555 ◽

Cited By ~ 1

Author(s):

K. Horvat-Karajz ◽

D. Grecea ◽

M. Smakal ◽

A. Illes ◽

Z. Kahan

Keyword(s):

Breast Cancer ◽

Clinical Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Chemotherapy Induced Neutropenia

Download Full-text

Phase III clinical study of maxacalcitol ointment in patients with palmoplantar pustulosis: A randomized, double-blind, placebo-controlled trial

The Journal of Dermatology ◽

10.1111/1346-8138.13064 ◽

2015 ◽

Vol 43 (3) ◽

pp. 288-293 ◽

Cited By ~ 12

Author(s):

Yoshinori Umezawa ◽

Hidemi Nakagawa ◽

Kunihiko Tamaki

Keyword(s):

Clinical Study ◽

Controlled Trial ◽

Phase Iii ◽

Palmoplantar Pustulosis ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A multi-center, randomized, double-blind, parallel, two-group phase III clinical study on the efficacy and safety of QL1101 or bevacizumab in combination with paclitaxel and carboplatin in the first-line treatment of non-squamous non-small cell lung cancer

Annals of Oncology ◽

10.1093/annonc/mdz063.070 ◽

2019 ◽

Vol 30 ◽

pp. ii62

Author(s):

B. Han ◽

K. Li ◽

T. Chu ◽

M. Bi ◽

H. Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Study ◽

Small Cell ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

Small Cell Lung ◽

First Line ◽

Double Blind ◽

First Line Treatment

Download Full-text

Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study

Drug Design Development and Therapy ◽

10.2147/dddt.s116847 ◽

2016 ◽

Vol Volume 10 ◽

pp. 3817-3826 ◽

Cited By ~ 3

Author(s):

Sang-Hyun Ihm ◽

Hui-Kyung Jeon ◽

Tae-Joon Cha ◽

Taek-Jong Hong ◽

Sang-Hyun Kim ◽

...

Keyword(s):

Clinical Study ◽

Phase Iii ◽

Fixed Dose ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

A prospective, randomised, double-blind, multicentre, phase III clinical study on transarterial chemoembolisation (TACE) combined with sorafenib versus TACE plus placebo in patients with hepatocellular cancer (HCC) before liver transplantation (LTx) -Heidelberg Liver Cancer Study (HeiLivCa Study)

http://isrctn.org/> ◽

10.1186/isrctn24081794 ◽

2013 ◽

Author(s):

Peter Schemmer

Keyword(s):

Liver Transplantation ◽

Clinical Study ◽

Liver Cancer ◽

Hepatocellular Cancer ◽

Phase Iii ◽

Double Blind ◽

Transarterial Chemoembolisation ◽

Multicentre Phase ◽

Cancer Study

Download Full-text

Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib®versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation – HeiLivCa [ISRCTN24081794]

BMC Cancer ◽

10.1186/1471-2407-8-349 ◽

2008 ◽

Vol 8 (1) ◽

Cited By ~ 69

Author(s):

K Hoffmann ◽

H Glimm ◽

B Radeleff ◽

G Richter ◽

C Heining ◽

...

Keyword(s):

Liver Transplantation ◽

Clinical Study ◽

Transarterial Chemoembolization ◽

Hepatocellular Cancer ◽

Phase Iii ◽

Double Blind

Download Full-text

Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: results of a randomized, double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy

BMC Cancer ◽

10.1186/s12885-019-5329-6 ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 1

Author(s):

Zsuzsanna Kahan ◽

Daniela Grecea ◽

Martin Smakal ◽

Sergei Tjulandin ◽

Igor Bondarenko ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Chemotherapy Induced Neutropenia

Download Full-text

Efficacy and Safety of DP-R202 in Patients with Chronic Artery Occlusive Disease: Multicenter Randomized Double-blind Active-controlled Parallel Group Phase III Clinical Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2016.01.009 ◽

2016 ◽

Vol 38 (3) ◽

pp. 557-573 ◽

Cited By ~ 1

Author(s):

Han Cheol Lee ◽

Sang-Rok Lee ◽

Kyoo-Rok Han ◽

Cheol-Woong Yu ◽

Chang-Gyu Park ◽

...

Keyword(s):

Clinical Study ◽

Occlusive Disease ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Parallel Group

Download Full-text